Literatur

Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis

In: Korean J. Intern. Med. 37, S. 949–957. DOI: 10.3904/kjim.2021.458.

Weitere Veröffentlichungen:

Chronische Obstipation, Vergleich von mikrobiologischer Therapie und Lactulose.

Weitere Informationen

Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents. An open-label pilot study.

Weitere Informationen

Probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Weitere Informationen

Park, Soo-Kyung; Kang, Sang-Bum; Kim, SangSoo; Kim, Tae Oh; Cha, Jae Myung; Im, Jong Pil et al. (2022): Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis.